The FCF Life Sciences Biotech Venture Capital Monitor – USA is a monthly published overview of venture capital trends in the US-Biotech sector.
LIFE SCIENCES RESEARCH SERIES
We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:
Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Biotech Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
Life Sciences Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Biotech Public Equity MonitorRecent valuations of listed European Life Sciences companies
Life Sciences IPO ReportRecent IPO trends in the Life Sciences sector
Biotech Licensing Monitor – China-Upcoming-Recent licensing trends of European Biotech companies in China
MedTech Public Equity Monitor-Upcoming-Recent valuations of listed MedTech companies
Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Biotech Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
Life Sciences Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Biotech Licensing Monitor – China-Upcoming-Recent licensing trends of European Biotech companies in China
Life Sciences IPO ReportRecent IPO trends in the Life Sciences sector
Biotech Public Equity MonitorRecent valuations of listed European Life Sciences companies
MedTech Public Equity Monitor-Upcoming-Recent valuations of listed MedTech companies
NEWS & PRESS
FCF Biotech Venture Capital Monitor – USA 12/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2020”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences Venture Capital Monitor – Europe 11/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2020”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Biotech Public Equity Monitor – November 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Public Equity Monitor – November 2020”. The Biotech Public Equity Monitor, part of FCF Life Sciences Research Series, is the most detailed
Dr. Axel Polack becomes the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH
The Munich-based corporate financing specialist welcomes yet another highly regarded authority to its Life Sciences Advisory Board. Munich, December 15, 2020 The newest member of the Life Sciences Advisory Board at FCF Fox Corporate Finance
FCF Biotech Venture Capital Monitor – USA 11/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2020”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
